Intersect ENT Sees Q4 Revenues Above Street

(RTTNews) - Intersect ENT Inc. (XENT), Monday said it expects fourth-quarter revenues of $13.2 to $13.4 million, an increase of about 91 percent from last year. Analysts polled by Thomson Reuters expect revenues of $11.45 million for the quarter.

For the full year 2014, revenues is expected to be $38.4 to $38.6 million. Analysts estimate revenues of $36.6 million for the year.

"We are pleased to have more than doubled sales of PROPEL and PROPEL mini in 2014 compared with 2013, reflecting growth both from our base of established users as well as the addition of over 700 new accounts," said Lisa Earnhardt, president and CEO of Intersect ENT.